Yestar Healthcare Holdings Company Limited announced that noteholders holding Notes in aggregate principal amount of $166,679,000, representing approximately 89.5% by value of the aggregate outstanding principal amount of the Notes (being $186,323,000 after cancellation of the Notes repurchased by the Company on market in 2021), have entered into or acceded to the New RSA. In order to encourage more noteholders to accede to the New RSA and support the Proposed Restructuring and in accordance with the terms of the New RSA, the Company hereby announces the extension of the Consent Fee Deadline from 5:00 p.m. (Hong Kong time) on 20 October 2021 to 8:00 p.m. (Hong Kong time) on 1 December 2021.